RadNet, Inc.
RDNT
Classement en actions
#3236
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Prix de l'action
$69.56
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$5.47B
Changement (1 jour)
1.10%
Changement (1 an)
-11.33%
Pays
US
Échange RadNet, Inc. (RDNT)
Catégorie
Healthcare
Ratio P/B pour RadNet, Inc. (RDNT)
Ratio P/B au October 2026 TTM : 4.91
Selon les derniers rapports financiers et le cours de l'action de RadNet, Inc., le ratio cours/valeur comptable actuel (TTM) est 4.91. À la fin de 2023, le ratio P/B était de 3.51.
Historique du ratio P/B pour RadNet, Inc. de 2000 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 4.91 | -13.13% |
| 2024 | 5.65 | 61.28% |
| 2023 | 3.51 | 10.11% |
| 2022 | 3.18 | -53.90% |
| 2021 | 6.91 | 14.92% |
| 2020 | 6.01 | -9.61% |
| 2019 | 6.65 | 72.79% |
| 2018 | 3.85 | -49.98% |
| 2017 | 7.69 | 25.03% |
| 2016 | 6.15 | -25.97% |
| 2015 | 8.31 | -87.30% |
| 2014 | 65.41 | -108.01% |
| 2013 | -817.06 | 2,154.14% |
| 2012 | -36.25 | 3,122.23% |
| 2011 | -1.12 | -10.67% |
| 2010 | -1.26 | 28.12% |
| 2009 | -0.98 | -33.38% |
| 2008 | -1.48 | -70.66% |
| 2007 | -5.03 | 266.81% |
| 2006 | -1.37 | 534.92% |
| 2005 | -0.22 | -37.47% |
| 2004 | -0.35 | -0.98% |
| 2003 | -0.35 | -45.70% |
| 2002 | -0.64 | -22.79% |
| 2001 | -0.83 | 188.72% |
| 2000 | -0.29 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 4.7411 | -3.40% |
US
|
|
| 3.0143 | -38.59% |
US
|
|
| 31.051 | 532.64% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | 35.77% |
US
|
